GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Winston Medical Supply Co Ltd (ROCO:6817) » Definitions » EBIT

Winston Medical Supply Co (ROCO:6817) EBIT : NT$165.4 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Winston Medical Supply Co EBIT?

Winston Medical Supply Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was NT$84.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$165.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Winston Medical Supply Co's annualized ROC % for the quarter that ended in Dec. 2024 was 35.05%. Winston Medical Supply Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 96.89%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Winston Medical Supply Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 10.46%.


Winston Medical Supply Co EBIT Historical Data

The historical data trend for Winston Medical Supply Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winston Medical Supply Co EBIT Chart

Winston Medical Supply Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial 88.87 118.43 142.46 200.35 165.35

Winston Medical Supply Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.57 91.77 108.58 80.77 84.58

Competitive Comparison of Winston Medical Supply Co's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Winston Medical Supply Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Winston Medical Supply Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Winston Medical Supply Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Winston Medical Supply Co's EV-to-EBIT falls into.


;
;

Winston Medical Supply Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$165.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Winston Medical Supply Co  (ROCO:6817) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Winston Medical Supply Co's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=162.706 * ( 1 - 19.36% )/( (364.438 + 384.226)/ 2 )
=131.2061184/374.332
=35.05 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=831.216 - 223.29 - ( 355.412 - max(0, 391.225 - 634.713+355.412))
=364.438

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=812.673 - 128.895 - ( 299.552 - max(0, 310.702 - 624.023+299.552))
=384.226

Note: The Operating Income data used here is two times the semi-annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Winston Medical Supply Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=169.158/( ( (179.716 + max(-150.2, 0)) + (169.467 + max(-16.213, 0)) )/ 2 )
=169.158/( ( 179.716 + 169.467 )/ 2 )
=169.158/174.5915
=96.89 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(58.743 + 125.516 + 8.308) - (223.29 + 0 + 119.477)
=-150.2

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(80.504 + 149.673 + 9.4689999999999) - (128.895 + 0 + 126.964)
=-16.213

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Winston Medical Supply Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=165.351/1580.692
=10.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Winston Medical Supply Co EBIT Related Terms

Thank you for viewing the detailed overview of Winston Medical Supply Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Winston Medical Supply Co Business Description

Traded in Other Exchanges
N/A
Address
117 Renai Street, Yanzhouli, Yongkang District, Tainan, TWN, 710
Winston Medical Supply Co Ltd is a manufacturer of medical products. It produces sterile ophthalmic preparations, hormone preparations and healthy products.

Winston Medical Supply Co Headlines

No Headlines